LT
Lotus Pharmaceuticals, Inc.
LTUS · OTC
$0.00 +0.00% (+$0.00)
1M -23.08%
Market Cap $85.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/FCF N/A
P/E N/A
P/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 330.99%
ROA 331.14%
Debt
70 /100
Low Net debt/EBITDA -6.10x
Current ratio 0.05x
Debt/Assets N/A
Stability
33 /100
Unstable Profitable years 0
Beta -1.60x
EPS volatility N/A
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o LTUS
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Zhong Yi Liu
Employees
233
Headquarters
Irvine